John Overdeck’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,000
| Closed | -$836K | – | 5201 |
|
|
2026
Q1 | $836K | Hold |
6,000
| – | – | ﹤0.01% | 3396 |
|
|
2025
Q4 | $736K | Buy |
+6,000
| New | +$729K | ﹤0.01% | 3109 |
|
|
2022
Q1 | – | Sell |
-182,400
| Closed | -$13.2M | – | 3296 |
|
|
2021
Q4 | $13.2M | Sell |
182,400
-5,100
| -3% | -$351K | 0.03% | 653 |
|
|
2021
Q3 | $13.1M | Sell |
187,500
-58,900
| -24% | -$4.14M | 0.03% | 643 |
|
|
2021
Q2 | $17M | Sell |
246,400
-299,400
| -55% | -$20M | 0.04% | 558 |
|
|
2021
Q1 | $35.3M | Buy |
545,800
+279,000
| +105% | +$18M | 0.09% | 250 |
|
|
2020
Q4 | $15.5M | Sell |
266,800
-28,600
| -10% | -$1.73M | 0.04% | 445 |
|
|
2020
Q3 | $18.7M | Buy |
295,400
+186,800
| +172% | +$13M | 0.07% | 314 |
|
|
2020
Q2 | $8.36M | Buy |
108,600
+85,100
| +362% | +$6.52M | 0.04% | 448 |
|
|
2020
Q1 | $1.76M | Sell |
23,500
-13,800
| -37% | -$954K | 0.01% | 1033 |
|
|
2019
Q4 | $2.42M | Sell |
37,300
-187,900
| -83% | -$12.2M | 0.01% | 1439 |
|
|
2019
Q3 | $14.3M | Buy |
225,200
+114,000
| +103% | +$7.45M | 0.05% | 442 |
|
|
2019
Q2 | $7.51M | Sell |
111,200
-133,300
| -55% | -$8.77M | 0.03% | 719 |
|
|
2019
Q1 | $15.9M | Buy |
244,500
+188,500
| +337% | +$12.5M | 0.05% | 477 |
|
|
2018
Q4 | $3.5M | Buy |
56,000
+46,200
| +471% | +$3.23M | 0.01% | 965 |
|
|
2018
Q3 | $757K | Sell |
9,800
-207,200
| -95% | -$15.6M | ﹤0.01% | 2179 |
|
|
2018
Q2 | $15.4M | Buy |
217,000
+122,500
| +130% | +$8.65M | 0.05% | 503 |
|
|
2018
Q1 | $7.12M | Buy |
94,500
+73,600
| +352% | +$5.85M | 0.02% | 755 |
|
|
2017
Q4 | $1.5M | Sell |
20,900
-41,100
| -66% | -$3.12M | ﹤0.01% | 1688 |
|
|
2017
Q3 | $5.02M | Buy |
62,000
+7,400
| +14% | +$566K | 0.02% | 801 |
|
|
2017
Q2 | $3.87M | Buy |
54,600
+30,600
| +128% | +$2.04M | 0.01% | 999 |
|
|
2017
Q1 | $1.63M | Sell |
24,000
-112,300
| -82% | -$7.9M | 0.01% | 1581 |
|
|
2016
Q4 | $9.76M | Buy |
136,300
+85,300
| +167% | +$6.34M | 0.04% | 540 |
|
|
2016
Q3 | $4.04M | Buy |
51,000
+26,000
| +104% | +$2.11M | 0.01% | 998 |
|
|
2016
Q2 | $2.09M | Sell |
25,000
-58,000
| -70% | -$5.15M | 0.01% | 1237 |
|
|
2016
Q1 | $7.62M | Buy |
83,000
+31,000
| +60% | +$2.8M | 0.04% | 536 |
|
|
2015
Q4 | $5.26M | Buy |
52,000
+27,000
| +108% | +$2.81M | 0.03% | 650 |
|
|
2015
Q3 | $2.46M | Buy |
25,000
+7,000
| +39% | +$777K | 0.01% | 761 |
|
|
2015
Q2 | $2.11M | Buy |
18,000
+5,000
| +38% | +$546K | 0.01% | 1160 |
|
|
2015
Q1 | $1.28M | Buy |
+13,000
| New | +$1.32M | 0.01% | 1429 |
|
Other funds holding GILD
John Overdeck's GILD Position: Q2 2026 in Review
John Overdeck increased its Gilead Sciences (GILD) stake by 2,931% in Q2 2026, buying an estimated $52.1M and bringing the position to 409,174 shares worth $51.7M. The position accounts for 0.04% of the portfolio, ranked #544.
John Overdeck first reported a position in GILD in Q2 2013 and has held it in 46 quarters since. The position peaked at $254M in Q4 2022. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- John Overdeck held 409,174 shares of Gilead Sciences worth $51.7M as of Q2 2026.
- John Overdeck bought 395,674 Gilead Sciences shares in Q2 2026, an estimated $52.1M.
- Gilead Sciences made up 0.04% of John Overdeck's portfolio in Q2 2026, its #544 holding.
- John Overdeck first reported a position in Gilead Sciences in Q2 2013 and has held it in 46 quarters since.
- John Overdeck's Gilead Sciences position peaked at $254M in Q4 2022.
- 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.